Clinical Trial Update: Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma [Phase 2]

View source ↗

Summary

Phase 2 study of CSJ117 in severe uncontrolled asthma terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CSJ117

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2023-08-07